S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55

GoHealth Stock Forecast, Price & News

-0.23 (-7.82%)
(As of 01/18/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.33 million shs
Average Volume
4.00 million shs
Market Capitalization
$869.12 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive GOCO News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

GoHealth logo

About GoHealth

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareÂInternal; MedicareÂExternal; Individual and Family Plans (IFP) and OtherÂInternal; and Individual and Family Plans and OtherÂExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carrier and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois.


GoHealth (NASDAQ:GOCO) Stock Rating Lowered by Credit Suisse Group
January 7, 2022 |  americanbankingnews.com
GoHealth (NASDAQ:GOCO) Shares Down 3.8%
January 7, 2022 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Insurance agents, brokers, & service
Year Founded

Sales & Book Value

Annual Sales
$877.35 million
Cash Flow
$0.82 per share
Book Value
$4.36 per share


Net Income
$-44.27 million
Pretax Margin




Free Float
Market Cap
$869.12 million
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.86 out of 5 stars

Finance Sector

96th out of 1,349 stocks

Insurance Agents, Brokers, & Service Industry

7th out of 25 stocks

Analyst Opinion: 4.1Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 2.5 5 -4 -3 -2 -1 -

GoHealth (NYSE:GOCO) Frequently Asked Questions

Is GoHealth a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GoHealth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GOCO, but not buy additional shares or sell existing shares.
View analyst ratings for GoHealth
or view top-rated stocks.

Are investors shorting GoHealth?

GoHealth saw a increase in short interest during the month of December. As of December 15th, there was short interest totaling 6,400,000 shares, an increase of 30.9% from the November 30th total of 4,890,000 shares. Based on an average trading volume of 2,580,000 shares, the days-to-cover ratio is currently 2.5 days.
View GoHealth's Short Interest

When is GoHealth's next earnings date?

GoHealth is scheduled to release its next quarterly earnings announcement on Monday, March 14th 2022.
View our earnings forecast for GoHealth

How were GoHealth's earnings last quarter?

GoHealth, Inc. (NYSE:GOCO) posted its earnings results on Tuesday, November, 9th. The company reported ($0.18) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.09) by $0.09. The business had revenue of $211.73 million for the quarter, compared to the consensus estimate of $202.82 million. GoHealth had a trailing twelve-month return on equity of 0.81% and a net margin of 0.16%. During the same quarter in the prior year, the firm earned $1.82 EPS.
View GoHealth's earnings history

What guidance has GoHealth issued on next quarter's earnings?

GoHealth updated its FY 2021 earnings guidance on Tuesday, December, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.20 billion-$1.30 billion, compared to the consensus revenue estimate of $1.26 billion.

What price target have analysts set for GOCO?

8 analysts have issued 1-year price targets for GoHealth's stock. Their forecasts range from $3.00 to $20.00. On average, they expect GoHealth's stock price to reach $8.71 in the next twelve months. This suggests a possible upside of 221.6% from the stock's current price.
View analysts' price targets for GoHealth
or view top-rated stocks among Wall Street analysts.

Who are GoHealth's key executives?

GoHealth's management team includes the following people:
  • Mr. Brandon M. Cruz, Co-Founder, Co-Chair of the Board & Chief Strategy Officer (Age 43, Pay $1.75M) (LinkedIn Profile)
  • Mr. Clinton P. Jones, Co-Founder, Co-Chair of the Board of Directors & CEO (Age 43, Pay $1.31M) (LinkedIn Profile)
  • Mr. James A. Sharman, Pres (Age 62, Pay $862.24k)
  • Mr. Shane E. Cruz, Chief Operating Officer (Age 41, Pay $673.25k)
  • Mr. Travis J. Matthiesen, Chief Financial Officer (Age 37)
  • Ms. Ellen Wong, Chief Accounting Officer (Age 50)
  • Mr. Cem Varon, Chief Technology Officer
  • Mr. Jason Koval, VP of Investor Relations
  • Mr. Brian P. Farley, Chief Legal Officer & Corp. Sec. (Age 51)
  • Mr. Jarret Ditoro, Chief Marketing Officer

When did GoHealth IPO?

(GOCO) raised $750 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 39,500,000 shares at $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley served as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

What is GoHealth's stock symbol?

GoHealth trades on the New York Stock Exchange (NYSE) under the ticker symbol "GOCO."

Who are GoHealth's major shareholders?

GoHealth's stock is owned by a number of institutional and retail investors. Top institutional investors include FNY Investment Advisers LLC (0.00%) and Cutler Group LP (0.00%). Company insiders that own GoHealth stock include Anita Pramoda, Brandon M Cruz, Clinton P Jones, Clinton P Jones, Nvx Holdings, Inc, Shane E Cruz and Travis J Matthiesen.
View institutional ownership trends for GoHealth

Which major investors are selling GoHealth stock?

GOCO stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.
View insider buying and selling activity for GoHealth
or view top insider-selling stocks.

Which major investors are buying GoHealth stock?

GOCO stock was bought by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC. Company insiders that have bought GoHealth stock in the last two years include Anita Pramoda, Brandon M Cruz, Clinton P Jones, and Nvx Holdings, Inc.
View insider buying and selling activity for GoHealth
or or view top insider-buying stocks.

How do I buy shares of GoHealth?

Shares of GOCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GoHealth's stock price today?

One share of GOCO stock can currently be purchased for approximately $2.71.

How much money does GoHealth make?

GoHealth has a market capitalization of $869.12 million and generates $877.35 million in revenue each year. The company earns $-44.27 million in net income (profit) each year or $0.09 on an earnings per share basis.

How many employees does GoHealth have?

GoHealth employs 3,067 workers across the globe.

What is GoHealth's official website?

The official website for GoHealth is www.gohealth.com.

Where are GoHealth's headquarters?

GoHealth is headquartered at 214 WEST HURON STREET, CHICAGO IL, 60654.

How can I contact GoHealth?

GoHealth's mailing address is 214 WEST HURON STREET, CHICAGO IL, 60654. The company can be reached via phone at 312-386-8200 or via email at [email protected].

This page was last updated on 1/19/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.